Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), bought 138,780 shares at $2.91 ($397K) on 2022-06-22, disclosed to the SEC on 2022-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.79 | 29,082 | $81K | 20.4% |
| 2 | $2.79 | 29,082 | $81K | 20.4% |
| 3 | $2.91 | 40,308 | $117K | 29.6% |
| 4 | $2.91 | 40,308 | $117K | 29.6% |
| Total | $2.86 avg | 138,780 | $397K | 100% |
| Filing → |
| BCAB | BUY | 2022-08-15 | $207K | — | Filing → |
| BCAB | SELL | 2021-12-07 | $2.1M | — | Filing → |
| BCAB | SELL | 2021-12-06 | $737K | — | Filing → |